European Archives - Page 387 of 1144 - European Medical Journal

Biofilms and Innovations in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a leading cause of death. This review focuses on the development of biofilms, and…

Non-invasive Management of Atelectasis: A Case Report

The manuscript describes the physiotherapeutic techniques used and collects the main scientific evidence on them. The main purpose…

Anatomical Variant of the Right Upper Lobe Bronchus

The authors present a case of a 77-year-old female, a former smoker with a history of chronic obstructive pulmonary disease who underwent…

Dr Andreas Konieczny on leading with authenticity

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.

Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny

In this episode of GOLD podcast, the latest catalyst ImmunoGen’s Andreas Konieczny offers insights on driving drug launches and leadership skills. Listen now!

A podcast exploring the DaBlaCa-13 study, chemoresection with dose-dense mitomycin C (MMC) in patients with recurrent non-muscle-invasive bladder cancer (intermediate-risk)

Tune in for a fascinating discussion with Jørgen Bjerggaard Jensen, as he explores recent breakthroughs in non-muscle-invasive bladder cancer management through mitomycin C (MMC) chemoresection.

Inflammatory-Related Diseases an Early Sign of Type 2 Diabetes?

The present study assessed the clinical histories of pre- and post-Type 2 Diabetes diagnoses with the aim of gaining insight into causes and trajectories for health-related conditions, such as cardiovascular and pulmonary disorders.

Sudden Cardiac Arrest in Patients with Type 2 Diabetes

New research has identified a range of characteristics associated with an increased risk of sudden cardiac arrest in patients with Type 2 diabetes. However, it remains difficult to predict, especially in those without a history of cardiovascular disease.

Navigating the Complexities of Metastatic Colorectal Cancer: From Genetic Mutations to Targeted Therapies

Two experts in medical oncology explore the latest developments in metastatic colorectal cancer in this episode of the EMJ podcast.

Does a History of Cancer Increase Hearing Loss Risk?

According to research, the risk of hearing loss is greater in individuals who are survivors of cancer. This is due to age and the effects of previous chemotherapy and radiotherapy. Read more.